Themis Medicare Management
Management criteria checks 2/4
Themis Medicare's CEO is Sachin Patel, appointed in Feb 2017, has a tenure of 7.92 years. total yearly compensation is ₹26.21M, comprised of 77.1% salary and 22.9% bonuses, including company stock and options. directly owns 5.99% of the company’s shares, worth ₹1.50B. The average tenure of the management team and the board of directors is 7.9 years and 3.2 years respectively.
Key information
Sachin Patel
Chief executive officer
₹26.2m
Total compensation
| CEO salary percentage | 77.1% |
| CEO tenure | 7.9yrs |
| CEO ownership | 6.0% |
| Management average tenure | 7.9yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
Investor Optimism Abounds Themis Medicare Limited (NSE:THEMISMED) But Growth Is Lacking
Jan 21
What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You
Dec 27Themis Medicare (NSE:THEMISMED) Takes On Some Risk With Its Use Of Debt
Dec 01Themis Medicare (NSE:THEMISMED) Has Affirmed Its Dividend Of ₹5.00
Aug 18Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Aug 04Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Jul 18We Think Themis Medicare (NSE:THEMISMED) Is Taking Some Risk With Its Debt
Jul 08Themis Medicare (NSE:THEMISMED) Is Due To Pay A Dividend Of ₹5.00
May 18Themis Medicare (NSE:THEMISMED) Seems To Use Debt Quite Sensibly
Dec 21Themis Medicare (NSE:THEMISMED) Has Announced That It Will Be Increasing Its Dividend To ₹5.00
Aug 28Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹5.00
Aug 08Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
Jul 21Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
May 27Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
May 12Calculating The Fair Value Of Themis Medicare Limited (NSE:THEMISMED)
Nov 09Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
Oct 26Increases to Themis Medicare Limited's (NSE:THEMISMED) CEO Compensation Might Cool off for now
Sep 11Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹4.30
Aug 16Do Themis Medicare's (NSE:THEMISMED) Earnings Warrant Your Attention?
Jul 09CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹530m |
| Jun 30 2024 | n/a | n/a | ₹500m |
| Mar 31 2024 | ₹26m | ₹20m | ₹435m |
| Dec 31 2023 | n/a | n/a | ₹453m |
| Sep 30 2023 | n/a | n/a | ₹512m |
| Jun 30 2023 | n/a | n/a | ₹577m |
| Mar 31 2023 | ₹21m | ₹13m | ₹569m |
| Dec 31 2022 | n/a | n/a | ₹584m |
| Sep 30 2022 | n/a | n/a | ₹576m |
| Jun 30 2022 | n/a | n/a | ₹591m |
| Mar 31 2022 | ₹13m | ₹7m | ₹729m |
| Dec 31 2021 | n/a | n/a | ₹710m |
| Sep 30 2021 | n/a | n/a | ₹703m |
| Jun 30 2021 | n/a | n/a | ₹591m |
| Mar 31 2021 | ₹7m | ₹7m | ₹357m |
| Dec 31 2020 | n/a | n/a | ₹349m |
| Sep 30 2020 | n/a | n/a | ₹338m |
| Jun 30 2020 | n/a | n/a | ₹274m |
| Mar 31 2020 | ₹7m | ₹7m | ₹248m |
| Dec 31 2019 | n/a | n/a | ₹61m |
| Sep 30 2019 | n/a | n/a | -₹45m |
| Jun 30 2019 | n/a | n/a | -₹64m |
| Mar 31 2019 | ₹7m | ₹7m | -₹107m |
| Dec 31 2018 | n/a | n/a | ₹54m |
| Sep 30 2018 | n/a | n/a | ₹78m |
| Jun 30 2018 | n/a | n/a | ₹101m |
| Mar 31 2018 | ₹6m | ₹6m | ₹113m |
Compensation vs Market: Sachin's total compensation ($USD302.99K) is above average for companies of similar size in the Indian market ($USD184.31K).
Compensation vs Earnings: Sachin's compensation has increased by more than 20% in the past year.
CEO
Sachin Patel (49 yo)
7.9yrs
Tenure
₹26,206,000
Compensation
Dr. Sachin Dinesh Patel, Ph D., CChem. has been Chief Executive Officer and Managing Director of Themis Medicare Limited since February 14, 2017.He served as Deputy Managing Director at Themis Medicare Lt...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 17.6yrs | ₹26.21m | 10.55% ₹ 2.6b | |
| CEO, MD & Executive Director | 7.9yrs | ₹26.21m | 5.99% ₹ 1.5b | |
| VP of Systems & Administration and Alternate Non-Executive Non-Independent Director | no data | no data | 4.04% ₹ 1.0b | |
| Chief Financial Officer | 8.3yrs | ₹2.27m | no data |
7.9yrs
Average Tenure
Experienced Management: THEMISMED's management team is seasoned and experienced (7.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 17.6yrs | ₹26.21m | 10.55% ₹ 2.6b | |
| CEO, MD & Executive Director | 17.6yrs | ₹26.21m | 5.99% ₹ 1.5b | |
| VP of Systems & Administration and Alternate Non-Executive Non-Independent Director | 1.3yrs | no data | 4.04% ₹ 1.0b | |
| Non-Executive Director | 17.8yrs | ₹410.00k | 15.78% ₹ 3.9b | |
| Independent Director | 3.2yrs | ₹660.00k | no data | |
| Independent Director | 1.3yrs | ₹200.00k | no data | |
| Additional Independent Woman Director | 4.2yrs | ₹130.00k | no data | |
| Non-Executive Non-Independent Director | 1.3yrs | no data | no data | |
| Independent Director | less than a year | no data | 0.0054% ₹ 1.4m |
3.2yrs
Average Tenure
68yo
Average Age
Experienced Board: THEMISMED's board of directors are considered experienced (3.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 13:58 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Themis Medicare Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anil Burra | FirstCall Research |